搜索临床试验以:SHR-1702
总计2507个结果
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Shanghai Fosun Pharmaceutical Industrial Development...主动,不招人
-
TG Therapeutics, Inc.SCRI Development Innovations, LLC完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
TG Therapeutics, Inc.终止慢性淋巴细胞白血病 | 非霍奇金淋巴瘤美国
-
Bliss Biopharmaceutical (Hangzhou) Co., Ltd主动,不招人
-
TG Therapeutics, Inc.完全的
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.终止
-
Quark Pharmaceuticals完全的
-
Syneos HealthAsieris Pharmaceuticals (AUS) Pty Ltd.尚未招聘
-
Jiangsu Yahong Meditech Co., Ltd aka Asieris尚未招聘
-
Clarity Pharmaceuticals Ltd招聘中
-
The First Affiliated Hospital of Zhengzhou University尚未招聘
-
Shanghai Pulmonary Hospital, Shanghai, ChinaJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Staidson (Beijing) Biopharmaceuticals Co., Ltd完全的
-
Shanghai Hengrui Pharmaceutical Co., Ltd.招聘中
-
Eli Lilly and Company完全的A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)斑块状银屑病德国, 西班牙, 比利时, 法国, 匈牙利, 奥地利, 加拿大, 意大利, 荷兰, 波兰, 瑞典, 瑞士, 英国
-
Quark Pharmaceuticals终止